نتائج البحث - "Jean-Pierre Ghnassia"

المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA), Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER

المصدر: Annales de Pathologie
Annales de Pathologie, Elsevier Masson, 2021, ⟨10.1016/j.annpat.2021.07.014⟩

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292f83395888c73d5447eb356730dcd1
https://hal.archives-ouvertes.fr/hal-03333764

View record from ScienceDirect

6

Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort

المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA), Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER

المصدر: npj Breast Cancer, Vol 7, Iss 1, Pp 1-9 (2021)
npj Breast Cancer
npj Breast Cancer, Nature, 2021, 7 (1), ⟨10.1038/s41523-021-00252-6⟩
NPJ Breast Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, [SDV]Life Sciences [q-bio], medicine.medical_treatment, [SDV.CAN]Life Sciences [q-bio]/Cancer, Disease, Predictive markers, Article, Metastasis, 03 medical and health sciences, Breast cancer, 0302 clinical medicine, Internal medicine, Biopsy, medicine, Pharmacology (medical), Radiology, Nuclear Medicine and imaging, skin and connective tissue diseases, RC254-282, medicine.diagnostic_test, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Metastatic breast cancer, 3. Good health, 030104 developmental biology, Hormone receptor, 030220 oncology & carcinogenesis, Cohort, business, Adjuvant

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba74d9e680adfb3b37c5f19837953234
https://doi.org/10.1038/s41523-021-00252-6

Find this article in full text from ProQuest

7

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

المؤلفون: Richard Iggo, Jean-Michel Picquenot, Denis Larsimont, Véronique Becette, Jonas Bergh, Gaëtan MacGrogan, Jeremy Thomas, Olivier Kerdraon, Leen Slaets, David Cameron, Fanny Pommeret, C. Poncet, Jean-Christophe Tille, Frédéric Bibeau, Hervé Bonnefoi, Alexandre Bodmer, Jean-Pierre Ghnassia, Thomas Grellety

المساهمون: Donnat, Martin, Validation et identification de nouvelles cibles en oncologie (VINCO), Institut Bergonié [Bordeaux], UNICANCER-UNICANCER-Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), CIC Bordeaux, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de pathologie, UNICANCER-UNICANCER, UNICANCER, European Organisation for Research and Treatment of Cancer [Bruxelles] (EORTC), European Cancer Organisation [Bruxelles] (ECCO), Actions for OnCogenesis understanding and Target Identification in ONcology (ACTION), Institut Jules Bordet [Bruxelles], Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB), Hôpital René HUGUENIN (Saint-Cloud), Centre René Gauducheau, CRLCC René Gauducheau, Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre Paul Strauss, CRLCC Paul Strauss, Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Cancer Research UK Edinburgh Centre [Edinburgh, UK], University of Edinburgh-MRC Institute of Genetics and Molecular Medicine [Edinburgh] (IGMM), University of Edinburgh-Medical Research Council-Medical Research Council, Hôpitaux Universitaires de Genève (HUG), Department of Oncology-Pathology [Karolinska Institutet], Karolinska Institutet [Stockholm], Bordeaux PharmacoEpi, Inserm CIC1401, Université de Bordeaux, Université de Bordeaux (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Bergonié [Bordeaux], UNICANCER-UNICANCER-Université Bordeaux Segalen - Bordeaux 2, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Bordeaux Segalen - Bordeaux 2-Institut Bergonié [Bordeaux], Swiss Group for Clinical Cancer Research (SAKK)

المصدر: British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2019, 120 (9), pp.913-921. ⟨10.1038/s41416-019-0420-y⟩
Bonnefoi, H, MacGrogan, G, Poncet, C, Iggo, R, Pommeret, F, Grellety, T, Larsimont, D, Becette, V, Kerdraon, O, Bibeau, F, Ghnassia, J-P, Picquenot, J-M, Thomas, J, Tille, J-C, Slaets, L, Bodmer, A, Bergh, J & Cameron, D 2019, ' Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes ', British Journal of Cancer . https://doi.org/10.1038/s41416-019-0420-y
British Journal of Cancer, 120 (9
British Journal of Cancer, Vol. 120, No 9 (2019) pp. 913-921

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, Concordance, medicine.medical_treatment, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, ddc:616.07, Disease-Free Survival, Article, 03 medical and health sciences, Breast cancer, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Survival rate, Chemotherapy, business.industry, Gene Expression Profiling, Apocrine, medicine.disease, Immunohistochemistry, Subtyping, 3. Good health, Cancérologie, ErbB Receptors, Survival Rate, Clinical trial, Biological sciences, Treatment Outcome, Receptors, Estrogen, Chemotherapy, Adjuvant, Receptors, Androgen, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, 030220 oncology & carcinogenesis, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Female, Receptors, Progesterone, business

وصف الملف: application/pdf; 1 full-text file(s): application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8075ed5bffb4cfbba37e33a4360db84c
https://doi.org/10.1038/s41416-019-0420-y

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

8

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network

المؤلفون: Anne Moreau, Francois Collin, Anne Gomez-Brouchet, Jean François Emile, Marie Karanian-Philippe, François Gouin, Myriam Jean-Denis, Resos, Nicolas Ortonne, Emilie Angot, Céline Bazille, Laurent Doucet, Maxime Battistella, Antoine Italiano, Jean-Pierre Ghnassia, Gonzague de Pinieux, Marick Laé, Nouria Mesli, Isabelle Quintin-Rouet, Françoise Ducimetière, Sabrina Croce, Anne de Muret, Nathalie Stock, Repps, Isabelle Birtwisle-Peyrottes, Bruno Chetaille, Philippe Terrier, Jean-Baptiste Courrèges, Agnès Neuville, Yves-Marie Robin, Lenaig Mescam-Mancini, Juliane Berchoud, Philippe Rochaix, French Sarcoma Group-Groupe d’Etude des Tumeurs Osseuses, Nicolas Penel, Nicolas Macagno, Marie-Christine Chateau, Jean-Michel Coindre, Sophie Le Guellec, Corinne Bouvier, Isabelle Pommepuy, Frédérique Larousserie, Dominique Ranchère-Vince, Yohan Fayet, Sébastien Aubert, Sylvie Chabaud, Axel Le Cesne, Jean-Yves Blay, Céline Charon-Barra, Nicolas Weinbreck, Christophe Delfour, Florence Mishellany, Agnes Leroux, François Le Loarer, Isabelle Valo, Maud Toulmonde, Claire Chemin-Airiau

المساهمون: CHU Lille, CNRS, ENSCL, INRA, INSERM, Université de Lille, Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192, Institut de Pathologie [CHU Lille], Cancer Heterogeneity, Plasticity and Resistance to Therapies (CANTHER) - UMR 9020 - UMR 1277, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Marseille medical genetics - Centre de génétique médicale de Marseille (MMG), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Anatomo-Cyto-Pathologie et de NeuroPathologie [Hôpital de la Timone - APHM] (ACPNP), Aix Marseille Université (AMU)- Hôpital de la Timone [CHU - APHM] (TIMONE), ANR-17-CONV-0002,PLASCAN,Institut François Rabelais pour la recherche multidisciplinaire sur le cancer(2017), ANR-18-RHUS-0009,DEPGYN,Clinical proof of concept of dependence receptor targeting in gynecological Oncology(2018)

المصدر: PLoS ONE, Vol 16, Iss 2, p e0246958 (2021)
PLoS ONE
PLoS ONE, Public Library of Science, 2021, 16 (2), pp.e0246958. ⟨10.1371/journal.pone.0246958⟩
PLoS ONE, 2021, 16 (2), pp.e0246958. ⟨10.1371/journal.pone.0246958⟩

مصطلحات موضوعية: Male, Skin Neoplasms, Epidemiology, [SDV]Life Sciences [q-bio], 0302 clinical medicine, Epidemiology of cancer, Gastrointestinal Cancers, Medicine and Health Sciences, Angiosarcoma, Medicine, 030212 general & internal medicine, Prospective Studies, Neurological Tumors, Skin Tumors, 0303 health sciences, Multidisciplinary, GiST, Incidence (epidemiology), Incidence, Sarcoma, Middle Aged, 3. Good health, medicine.anatomical_structure, Oncology, Neurology, 030220 oncology & carcinogenesis, Female, France, Cancer Epidemiology, Research Article, Adult, medicine.medical_specialty, Adolescent, Metastatic tumors, Cancer epidemiology, Neurological tumors, Skin tumors, Gastrointestinal cancers, Malignant tumors, Science, Connective tissue, [SDV.CAN]Life Sciences [q-bio]/Cancer, Dermatology, Gastroenterology and Hepatology, Liposarcoma, Malignancy, World Health Organization, 03 medical and health sciences, Young Adult, Malignant Tumors, Humans, 030304 developmental biology, Aged, business.industry, Cancers and Neoplasms, Histology, medicine.disease, Clinical trial, Metastatic Tumors, Neoplasm Grading, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

وصف الملف: application/octet-stream

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb7196fd34e3d58013ded5edbf33720e
https://doaj.org/article/bc86ceb426d94d90885c555acf6aabc9

Find this article in full text from ProQuest

9

Treatment algorithm and prognostic factors for patients with stage I–III carcinoma of the anal canal: a 20-year multicenter study

المساهمون: GIGA [Université Liège], Université de Liège, Service d'Oncologie Médicale [CHRU Besançon], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA-Research), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)

المصدر: Modern Pathology
Modern Pathology, Nature Publishing Group: Open Access Hybrid Model Option B, 2021, 34 (1), pp.116-130. ⟨10.1038/s41379-020-0637-6⟩

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Pathology, medicine.medical_specialty, Anal Carcinoma, [SDV.CAN]Life Sciences [q-bio]/Cancer, Pathology and Forensic Medicine, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Carcinoma, Humans, Anal cancer, ComputingMilieux_MISCELLANEOUS, Aged, business.industry, Incidence, Incidence (epidemiology), Middle Aged, Anal canal, Anus Neoplasms, Prognosis, medicine.disease, Precision medicine, Progression-Free Survival, 3. Good health, Regimen, Treatment Outcome, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, business, Algorithms, Chemoradiotherapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a166aad4c870b9381fa15cb6094031fc
https://hal-univ-fcomte.archives-ouvertes.fr/hal-03169755

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

10

[Case 4: Epithelioid soft tissue tumor]

المؤلفون: Noëlle, Weingertner, Jean-Pierre, Ghnassia, François, Le Loarer

المصدر: Annales de pathologie. 40(4)

مصطلحات موضوعية: Diagnosis, Differential, Male, Carcinoma, Hemangioendothelioma, Hemangiosarcoma, Biomarkers, Tumor, Hemangioendothelioma, Epithelioid, Humans, Sarcoma, Soft Tissue Neoplasms, Biopsy, Large-Core Needle, Middle Aged, Immunohistochemistry

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::1507fd887a8483dacdf0ab9e26ee92b4
https://pubmed.ncbi.nlm.nih.gov/32147194

View record from ScienceDirect

تنقيح النتائج